VSL#3 placebo

DRUG2 trials

Sponsors

Bambino Gesù Hospital and Research Institute, Nottingham University Hospitals NHS Trust

Conditions

AscitesDecompensated CirrhosisObesity

Phase 2

VSL#3 and Spontaneous Bacterial Peritonitis

TerminatedNCT01701297

Nottingham University Hospitals NHS TrustAscites, Decompensated Cirrhosis

Start: 2012-02-29End: 2014-10-31Updated: 2016-10-28

Unknown Phase

Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90°

CompletedNCT01650025

Bambino Gesù Hospital and Research InstituteObesity

Start: 2012-08-31End: 2013-12-31Updated: 2017-01-31

Related Papers

Randomised clinical trial: the beneficial effects of <scp>VSL</scp>#3 in obese children with non‐alcoholic steatohepatitis

Alimentary Pharmacology & Therapeutics2014-04-16449 citations